KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

Vertex Pharmaceuticals (VRTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Terence ...

Dwyane Wade was diagnosed with a cancerous cyst in his kidneys, and the procedure to remove it led to him losing 40% of his ...

NBA legend Dwyane Wade has revealed he underwent surgery to remove 40 per cent of his right kidney after doctors discovered a ...

Dwyane Wade was diagnosed with cancer in 2023 and secretly battled the disease, the retired NBA legend revealed two years ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVXtm (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal ...

Former Marquette superstar and Basketball Hall of Famer Dwyane Wade opened up about a recent health scare that the public ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Dwyane Wade is opening up about a personal health update. In a clip of the latest episode of his podcast "The Why with Dwyane ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.